MEDICA LABMED FORUM: Four theme days on current issues, trends and innovations in laboratory medicine
Cancer and coronary diseases, infections and new anti-bacterial active substances, digitalization and artificial intelligence – these are some of the top topics that will be discussed at the MEDICA LABMED FORUM as part of the MEDICA 2023 trade fair.
The international trade fair for the healthcare and medical technology industry will be held on all four days of MEDICA (November 13 – 16, 2023) in Hall 1. High-caliber scientific stage programs will be offered daily from 10:30 am to 4:00 pm.
Day 1: Lab management
On November 13, MEDICA will start with two issues: the potential threat to the existence of small IVD companies and specialized labs posed by the “In-Vitro Diagnostics Regulation” (IVDR) and the use of artificial intelligence (AI) with new possibilities and also risks. Led by Prof. Astrid Petersmann (University of Oldenburg), in the morning there will be a professional discussion concerning the challenges posed by the new EU directive for the quality assurance of diagnostic tests, and how these can be overcome. In the afternoon, an equally exciting discussion will follow, about how artificial intelligence and machine learning will change work in laboratories.
Day 2: Advances in clinical diagnostics
On November 14, new developments in laboratory medicine within the fields of oncology and cardiology will be discussed under the leadership of Prof. Stefan Holdenrieder, German Heart Centre Munich.
Day 3: The perspective of young scientists
The third day of the forum (November 15) traditionally belongs to the next scientific generation in laboratory medicine. PD Dr Verena Haselmann, senior physician at the University Hospital Mannheim, will invite young colleagues to report on their current research and thus provide an outlook on the future of the scientific field.
Day 4: Innovation from an industry perspective
The last day of the MEDICA LABMED FORUM (November 16) will begin with an overview of diagnostic solutions that significantly reduce the time to pathogen identification, enabling the most effective therapeutic response at an early stage, rather than risky diagnostic loops and wasted time. Special attention will be paid to managing septicaemia through quick identification of the pathogen and the targeted use of antibiotics.
A look inside the world of “Next Generation Sequencing” (NGS) and bioinformatics will round off the event. The focus will be on characterizing the microbiome of newborns, a particularly vulnerable patient group.
Another established tradition at MEDICA is the presentation of future trends from the point of view of the diagnostics and life science industry – a part of the forum program that has been organized for years by Dr. Peter Quick, member of the board of the Diagnostics Industry Association (Verband der Diagnostica-Industrie, VDGH). This year, his association colleague Dr. Jan Gorka will participate for the first time as co-chairman. Both have chosen infectious diseases as the main topic for 2023.
More information about MEDICA LABMED FORUM: https://www.medica-tradefair.com/mlf2.